NCT07366346 Telehealth-Adapted Compensatory Training and Intervention for Cognition
| NCT ID | NCT07366346 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Florida |
| Condition | MCI |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-05-29 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2026-05-29 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to develop a five-week virtual cognitive training intervention for people with Mild Cognitive Impairment (MCI) based off an existing eight-week intervention. The main question it aims to answer is: • Is five weeks of training as good as eight weeks in improving cognition, quality of life, daily functioning, and mood, and in reducing caregiver burden? Researchers will compare five weeks of cognitive training to eight weeks of training to see if the shorter version is as effective as the full training. Participants will complete all activities virtually: * Complete a screening visit with a study partner (typically a family member, roommate, or close friend) to determine eligibility to participate in the study * Complete some tests of memory and thinking and some questionnaires * Attend weekly two-hour group cognitive training sessions with a trained group leader, for five or eight weeks * Redo the questionnaires and tests of memory and thinking immediately after completing the training, and three months after completing the training
Eligibility Criteria
Inclusion Criteria: * 65 years of age or older, less than 85 years * Have the ability to speak and understand English * Time and willingness to commit to the completion of this study * Availability of a study partner (typically a relative, spouse, offspring, or roommate) for initial and post-intervention testing * A global Clinical Dementia Rating scale (CDR) score of 0.5 and cognitive performance of \<26 on the Montreal Cognitive Assessment (MoCA) or \<19 on the MoCA-BLIND for categorization of MCI, as determined in the screening appointment. Exclusion Criteria: * Self-reported diagnosis of dementia or functional impairment that requires assistance * Recent changes in medications for memory (i.e., prescribed or changed medications for memory within 30 days) * Major psychiatric illness (schizophrenia, current substance dependence, or undertreated depression or anxiety), or 15-item Geriatric Depression Scale (GDS-15) score of eight or higher * Hearing, vision, or motor deficits that would interfere with standardized cognitive assessment or participation in study interventions: e.g., inability to hear through headphones (with or without hearing aids). If vision is corrected with lenses to appropriate levels, then participant will be eligible * No access to reliable, stable internet, OR * Current participation in another cognitive training program or treatment study.
Contact & Investigator
Cameron K Perrin, M.S.
PRINCIPAL INVESTIGATOR
University of Florida
Frequently Asked Questions
Who can join the NCT07366346 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, up to 84 Years, studying MCI. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07366346 currently recruiting?
Yes, NCT07366346 is actively recruiting participants. Contact the research team at c.perrin@phhp.ufl.edu for enrollment information.
Where is the NCT07366346 trial being conducted?
This trial is being conducted at Gainesville, United States.
Who is sponsoring the NCT07366346 clinical trial?
NCT07366346 is sponsored by University of Florida. The principal investigator is Cameron K Perrin, M.S. at University of Florida. The trial plans to enroll 100 participants.